1.
Clin Transplant
; 37(8): e15045, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37306944
RESUMO
The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in China at the end of 2019 has developed into a global outbreak, and COVID- 19 is an ongoing major public health issue. During the pandemic, transplant programs had to devise strategies to deal with the possibility of COVID-19-positive donors and recipients. We describe the case of a heart transplant recipient who tested positive with the SARS- CoV2 swab upon admission to our Unit of Cardiac Surgery when a suitable donor became available. Given his clinical status of end-stage heart failure and the absence of imaging and clinical signs suggestive of COVID-19, and his having been vaccinated with three doses, we decided to proceed with the transplant.
Assuntos
COVID-19 , Transplante de Coração , Humanos , SARS-CoV-2 , Doadores de Tecidos , China , Transplantados
2.
J Cardiovasc Med (Hagerstown)
; 25(3): 243-245, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38305142
3.
Braz J Cardiovasc Surg
; 38(2): 309-311, 2023 04 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36459473
4.